Latest Trials

Systemic therapy trial

CheckMate 914 : A Phase 3 Randomized Study Comparing Nivolumab and Ipilimumab Combination vs Placebo in...

This phase III trial is trying to determine whether the combination of two immunotherapy drugs (nivolumab and ipilimumab) is effective in preventing cancer recurrence in patients with renal cell carcinoma, who have had part or all of their kidney removed

Status : Recruiting

Systemic therapy trial

A Randomized, Double-blind, Placebo-controlled, Phase III Study Comparing the Combination...

This phase III trial is evaluating the addition of PDR001 biological therapy to two chemotherapy drugs (Dabrafenib and Trametinib) in patients with previously untreated metastatic BRAF V600 mutant melanoma

Status : Recruiting

Systemic therapy trial

Rare cancers : A Phase II Clinical Trial Evaluating Ipilimumab and Nivolumab in Combination for the...

This phase II trial is evaluating two immunotherapy drugs (Ipilimumab and Nivolumab) for the treatment of rare gastrointestinal, neuroendocrine and female reproductive cancers

Status : Recruiting

Systemic therapy trial

MORPHO : A Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Trial of the FLT3...

This phase III trial is comparing the outcomes of patients with acute myeloid leukaemia (AML) who receive an oral drug (gilteritinib) following stem cell transplantation, with those who receive stem cell transplantation alone

Status : Recruiting

Systemic therapy trial

KEYNOTE-355 : A Randomized, Double-Blind, Phase III Study of Pembrolizumab (MK-3475) Plus Chemotherapy...

This phase III trial is evaluating an immunotherapy drug (Pembrolizumab) in combination with (one of three) chemotherapy drugs, compared to chemotherapy alone, in patients with locally recurrent or metastatic triple negative breast cancer (TNBC)

Status : Recruiting

Systemic therapy trial

A Phase 1A/1B Multicenter, Open-label, Dose-escalation, and Dose-expansion Study to...

This phase I trial is evaluating a new biological therapy (AK-104) in adult patients with advanced solid cancers (excluding some blood cancers)

Status : Recruiting

Radiotherapy trial

EXPERT : A Randomised Phase III Trial of Adjuvant Radiation Therapy Versus Observation Following...

This phase III trial is examining personalised radiation therapy for low-risk early breast cancer

Status : Recruiting

Systemic therapy trial

A Randomized, Double-blind, Phase 2 Trial to Assess Safety and Efficacy of Lenvatinib at...

This phase II trial is evaluating two doses of Lenvatinib (an anti-cancer drug) in combination with Everolimus (an oral drug) in patients who have received prior treatment for Renal Cell Carcinoma

Status : Recruiting

Systemic therapy trial

BFAST : A Phase II/III Multicenter Study Evaluating the Efficacy and Safety of Multiple Targeted...

This phase II/III trial is evaluating different targeted therapy and immunotherapy treatments in patients with advanced or metastatic Non-Small Cell (NSC) Lung Cancer

Status : Recruiting

Systemic therapy trial

TAHOE : A Randomized, Open-label, Multicenter, Phase 3 Study of Rovalpituzumab Tesirine Compared...

This phase III trial is comparing two drugs (Rovalpituzumab Tesirine and Topotecan) in patients with advanced or metastatic Small Cell Lung Cancer (SCLC) that has gotten worse following front-line chemotherapy

Status : Recruiting

 

Looking for a trial? Use the search functionality to find the trial you are finding.